Antares Pharma, Inc (Nasdaq: ATRS) announced the issuance of U.S. Patents RE44846 and RE44847. These patents are reissued versions of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE